Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 123 of 1714:
113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133
Gene Compound Assay Inh Ic50 Ki View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit FLUOROMETHOLONE Calcium Channel Type L, Benzothiazepine 36% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit FLUOROMETHOLONE Calcium Channel Type L, Benzothiazepine 36% NoneNone NoneNone View
protein kinase C, epsilon LAMOTRIGINE Phorbol Ester 2% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit FLUOROMETHOLONE Calcium Channel Type L, Benzothiazepine 36% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit FLUOROMETHOLONE Calcium Channel Type L, Benzothiazepine 36% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 FLUOROMETHOLONE Calcium Channel Type L, Benzothiazepine 36% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase FLUCONAZOLE CYP450-1A2 Inhibition 36% NoneNone NoneNone View
nitric oxide synthase 2A (inducible, hepatocytes) GW-1929 Nitric Oxide Synthase, Inducible (iNOS) 36% NoneNone NoneNone View
nitric oxide synthase 2, inducible GW-1929 Nitric Oxide Synthase, Inducible (iNOS) 36% NoneNone NoneNone View
adrenergic receptor, alpha 1a TROGLITAZONE Adrenergic alpha1A 36% NoneNone NoneNone View
neuropeptide Y receptor Y1 TRIOXSALEN Neuropeptide Y1 36% NoneNone NoneNone View
endothelin receptor type A ECONAZOLE Endothelin ETA 36% NoneNone NoneNone View
phosphodiesterase 4C, cAMP-specific ECONAZOLE Phosphodiesterase PDE4 36% NoneNone NoneNone View
phosphodiesterase 4D ECONAZOLE Phosphodiesterase PDE4 36% NoneNone NoneNone View
phosphodiesterase 4B, cAMP specific ECONAZOLE Phosphodiesterase PDE4 36% NoneNone NoneNone View
phosphodiesterase 4A, cAMP specific ECONAZOLE Phosphodiesterase PDE4 36% NoneNone NoneNone View
epidermal growth factor receptor BENZO[A]PYRENE Protein Tyrosine Kinase, EGF Receptor 36% NoneNone NoneNone View
cannabinoid receptor 1 (brain) FENOFIBRATE Cannabinoid CB1 36% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) CIGLITAZONE Adrenergic alpha1D 36% NoneNone NoneNone View
dopamine receptor D4 ERGOCORNINE Dopamine D4.2 36% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B CIGLITAZONE Serotonin 5-HT2B 36% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B MEVASTATIN Serotonin 5-HT2B 36% NoneNone NoneNone View
chemokine (C-C motif) receptor 2 AURANOFIN Chemokine CCR2B 36% NoneNone NoneNone View
dopamine receptor D1A SULCONAZOLE Dopamine D1 36% NoneNone NoneNone View
endothelin receptor type A AURANOFIN Endothelin ETA 36% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 DANAZOL Serotonin 5-HT6 36% NoneNone NoneNone View
thromboxane A synthase 1 MIFEPRISTONE Thromboxane Synthetase 36% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) MIFEPRISTONE Thromboxane Synthetase 36% NoneNone NoneNone View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 ESTRONE Adenosine Transporter 36% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) ESTRONE CYP450-2C9 Inhibition 36% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 ESTRONE CYP450-2C9 Inhibition 36% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 ESTRONE Adenosine Transporter 36% NoneNone NoneNone View
concentrative Na+ nucleoside cotransporter (DBSS) ESTRONE Adenosine Transporter 36% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 ESTRONE Adenosine Transporter 36% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma VALETHAMATE BROMIDE Sodium Channel, Site 2 38% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta VALETHAMATE BROMIDE Sodium Channel, Site 2 38% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) VALETHAMATE BROMIDE Sodium Channel, Site 2 38% NoneNone NoneNone View
epidermal growth factor receptor FLUNARIZINE Protein Tyrosine Kinase, EGF Receptor 38% NoneNone NoneNone View
mitogen activated protein kinase 14 EPINEPHRINE Protein Serine/Threonine Kinase, p38alpha 38% NoneNone NoneNone View
mitogen-activated protein kinase 14 EPINEPHRINE Protein Serine/Threonine Kinase, p38alpha 38% NoneNone NoneNone View
cholinergic receptor, muscarinic 5 DOMPERIDONE Muscarinic M5 38% NoneNone NoneNone View
monoamine oxidase A RILUZOLE Monoamine Oxidase MAOA 38% NoneNone NoneNone View
monoamine oxidase A RILUZOLE Monoamine Oxidase MAOA 38% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 IMATINIB GABAA, Benzodiazepine, Central 38% NoneNone NoneNone View
melanocortin 3 receptor CETYLPYRIDINIUM BROMIDE Melanocortin MC3 37% NoneNone NoneNone View
melanocortin 3 receptor CETYLPYRIDINIUM BROMIDE Melanocortin MC3 37% NoneNone NoneNone View
cholinergic receptor, muscarinic 5 SIBUTRAMINE Muscarinic M5 37% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 LACIDIPINE Serotonin 5-HT6 37% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 DAPIPRAZOLE Serotonin Transporter 37% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 NISOLDIPINE Adenosine Transporter 37% NoneNone NoneNone View
concentrative Na+ nucleoside cotransporter (DBSS) NISOLDIPINE Adenosine Transporter 37% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 NISOLDIPINE Adenosine Transporter 37% NoneNone NoneNone View
adenine nucleotide translocase (DBSS) (Non-specific probe) NISOLDIPINE Adenosine Transporter 37% NoneNone NoneNone View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 NISOLDIPINE Adenosine Transporter 37% NoneNone NoneNone View
chemokine (C-C motif) receptor 4 NIMESULIDE Chemokine CCR4 37% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 9 BAY 11-7085 Nicotinic Acetylcholine, Central 37% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 10 BAY 11-7085 Nicotinic Acetylcholine, Central 37% NoneNone NoneNone View
cholinergic receptor, nicotinic, epsilon polypeptide BAY 11-7085 Nicotinic Acetylcholine, Central 37% NoneNone NoneNone View
cholinergic receptor, nicotinic, beta polypeptide 4 BAY 11-7085 Nicotinic Acetylcholine, Central 37% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 5 BAY 11-7085 Nicotinic Acetylcholine, Central 37% NoneNone NoneNone View
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) BAY 11-7085 Nicotinic Acetylcholine, Central 37% NoneNone NoneNone View
dopamine receptor D4 DROPERIDOL Dopamine D4.2 37% NoneNone NoneNone View
adrenergic receptor, beta 3 ANTIMYCIN A Adrenergic beta3 37% NoneNone NoneNone View
adrenergic receptor, alpha 1a HOMATROPINE HYDROBROMIDE Adrenergic alpha1A 37% NoneNone NoneNone View
leukotriene B4 receptor 2 HALOPROGIN Leukotriene B4 37% NoneNone NoneNone View
leukotriene B4 receptor HALOPROGIN Leukotriene B4 37% NoneNone NoneNone View
leukotriene B4 receptor HALOPROGIN Leukotriene B4 37% NoneNone NoneNone View
leukotriene B4 receptor 2 HALOPROGIN Leukotriene B4 37% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 5B EMETINE Serotonin 5-HT4 37% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 4 EMETINE Serotonin 5-HT4 37% NoneNone NoneNone View
thromboxane A synthase 1 TRIOXSALEN Thromboxane Synthetase 37% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) TRIOXSALEN Thromboxane Synthetase 37% NoneNone NoneNone View
phosphodiesterase 4D IMIQUIMOD Phosphodiesterase PDE4 37% NoneNone NoneNone View
phosphodiesterase 4B, cAMP specific IMIQUIMOD Phosphodiesterase PDE4 37% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 KETOTIFEN Adrenergic, Norepinephrine Transporter 37% NoneNone NoneNone View
DNA encoding receptor of vasoactive intestinal polypeptide NIMETAZEPAM Vasoactive Intestinal Peptide VIP1 37% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2D NORTRIPTYLINE Glutamate, NMDA, Phencyclidine 37% NoneNone NoneNone View
glutamate receptor, ionotropic, NMDA2C NORTRIPTYLINE Glutamate, NMDA, Phencyclidine 37% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2B NORTRIPTYLINE Glutamate, NMDA, Phencyclidine 37% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2A NORTRIPTYLINE Glutamate, NMDA, Phencyclidine 37% NoneNone NoneNone View
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) NORTRIPTYLINE Glutamate, NMDA, Phencyclidine 37% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B NORTRIPTYLINE Glutamate, NMDA, Phencyclidine 37% NoneNone NoneNone View
mitogen activated protein kinase 1 NIMODIPINE Protein Serine/Threonine Kinase, ERK2 37% NoneNone NoneNone View
mitogen-activated protein kinase 1 NIMODIPINE Protein Serine/Threonine Kinase, ERK2 37% NoneNone NoneNone View
opioid receptor, kappa 1 NORETHINDRONE Opiate kappa 37% NoneNone NoneNone View
adrenergic receptor, alpha 2a OXYBUTYNIN Adrenergic alpha2A 37% NoneNone NoneNone View
adrenergic receptor, alpha 2a ONDANSETRON Imidazoline I2, Central 37% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) ONDANSETRON Imidazoline I2, Central 37% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 5B OXYBUTYNIN Serotonin 5-HT4 37% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 4 OXYBUTYNIN Serotonin 5-HT4 37% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta TROXIPIDE Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta METHAPYRILENE Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha METHAPYRILENE Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha METHAPYRILENE Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha METHAPYRILENE Sodium Channel, Site 2 37% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal METHAPYRILENE Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta METHAPYRILENE Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide METHAPYRILENE Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha METHAPYRILENE Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta METHAPYRILENE Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide METHAPYRILENE Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide METHAPYRILENE Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide METHAPYRILENE Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta METHAPYRILENE Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha METHAPYRILENE Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel associated protein 1 LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel associated protein 2 LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha LEVOBUNOLOL Sodium Channel, Site 2 37% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha NIMODIPINE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta ANDROSTERONE Sodium Channel, Site 2 36% NoneNone NoneNone View
neuropeptide Y receptor Y2 DIPHENIDOL Neuropeptide Y2 36% NoneNone NoneNone View
neuropeptide Y receptor Y2 DIPHENIDOL Neuropeptide Y2 36% NoneNone NoneNone View
adrenergic receptor, alpha 1b AMITRAZ Adrenergic alpha1B 36% NoneNone NoneNone View
thromboxane A synthase 1 ABAMECTIN Thromboxane Synthetase 36% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) ABAMECTIN Thromboxane Synthetase 36% NoneNone NoneNone View
adrenergic receptor, alpha 2a BROMHEXINE Imidazoline I2, Central 36% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) BROMHEXINE Imidazoline I2, Central 36% NoneNone NoneNone View
androgen receptor BROMHEXINE Testosterone 36% NoneNone NoneNone View
melanocortin 4 receptor MAPROTILINE Melanocortin MC4 36% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 5B AMPHOTERICIN B Serotonin 5-HT4 36% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 4 AMPHOTERICIN B Serotonin 5-HT4 36% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, theta BROMHEXINE GABAA, Chloride Channel, TBOB 36% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, gamma 2 BROMHEXINE GABAA, Chloride Channel, TBOB 36% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 BROMHEXINE GABAA, Chloride Channel, TBOB 36% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 BROMHEXINE GABAA, Chloride Channel, TBOB 36% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 2 BROMHEXINE GABAA, Chloride Channel, TBOB 36% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 1 BROMHEXINE GABAA, Chloride Channel, TBOB 36% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 BROMHEXINE GABAA, Chloride Channel, TBOB 36% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 BROMHEXINE GABAA, Chloride Channel, TBOB 36% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, delta BROMHEXINE GABAA, Chloride Channel, TBOB 36% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 BROMHEXINE GABAA, Chloride Channel, TBOB 36% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 BROMHEXINE GABAA, Chloride Channel, TBOB 36% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, gamma 1 BROMHEXINE GABAA, Chloride Channel, TBOB 36% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, pi BROMHEXINE GABAA, Chloride Channel, TBOB 36% NoneNone NoneNone View
AT hook, DNA binding motif, containing 1 (DBSS) BROMHEXINE GABAA, Chloride Channel, TBOB 36% NoneNone NoneNone View
arginine vasopressin receptor 1A OXCARBAZEPINE Vasopressin V1A 36% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) (S)-(-)-PINDOLOL Adrenergic alpha1D 36% NoneNone NoneNone View
androgen receptor VX-745 Testosterone 36% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 NELFINAVIR Adenosine Transporter 36% NoneNone NoneNone View
concentrative Na+ nucleoside cotransporter (DBSS) NELFINAVIR Adenosine Transporter 36% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 NELFINAVIR Adenosine Transporter 36% NoneNone NoneNone View
adenine nucleotide translocase (DBSS) (Non-specific probe) NELFINAVIR Adenosine Transporter 36% NoneNone NoneNone View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 NELFINAVIR Adenosine Transporter 36% NoneNone NoneNone View
melanocortin 5 receptor TERCONAZOLE Melanocortin MC5 36% NoneNone NoneNone View